Prospect: information for the user

Duloxetina STADA30mg hard-gastrorresistant capsulesEFG

Read this prospect carefully before starting to take this medicine, because it contains important information for you.

-Keep this prospect, as you may need to read it again.

-If you have any doubts, consult your doctor or pharmacist.

-This medicine has been prescribed only for you and should not be given to other people even if they have the same symptoms as you, as it may harm them.

-If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this prospect. See section 4.

1.What is Duloxetina Stada and for what it is used

2.What you need to know before starting to take Duloxetina Stada

3.How to take Duloxetina Stada

4.Possible adverse effects

5.Storage of Duloxetina Stada

6.Contents of the package and additional information

Duloxetina Stada contains the active ingredient duloxetina. Duloxetina increases the levels of serotonin and noradrenaline in the nervous system.

Duloxetina is used in adults to treat:

•depression

•generalized anxiety disorder (chronic feeling of anxiety or nervousness)

•diabetic neuropathic pain (often described as burning, stabbing, pinching, stinging, or electric shock-like pain. There may be a loss of sensation in the affected area, or pain may occur when touching the area or exposing it to heat, cold, or pressure)

Duloxetina begins to take effect in most people with depression or anxiety within two weeks of starting treatment, but it may take between 2 and 4 weeks to start feeling better. Inform your doctor if you do not notice improvement after this time. Your doctor may continue to give you duloxetina when you are feeling better to prevent your depression or anxiety from returning.

In people with diabetic neuropathic pain, it may take several weeks to start feeling better. Consult your doctor if you do not feel better after 2 months.

Do not take Duloxetina Stada:

-if you are allergic to duloxetine or any of the other ingredients in this medicine (listed in section 6)

-if you have liver failure

-if you have severe kidney failure

-if you are taking or have taken in the last 14 days another medicine known as a monoamine oxidase inhibitor (MAOI) (see “Other medicines and Duloxetina Stada”)

-if you are taking fluvoxamine, which is usually used to treat depression, ciprofloxacin or enoxacin, which are used in the treatment of some infections

-if you are taking other medicines that contain duloxetine (see “Other medicines and Duloxetina Stada”).

Consult your doctor if you have high blood pressure or a heart condition. Your doctor will tell you if you should take duloxetine.

Warnings and precautions

Duloxetine may not be suitable for you for the following reasons.Consult your doctor before starting to take this medicineif:

-you are taking other medicines to treat depression (see “Other medicines and Duloxetina Stada”)

-you are taking St. John's Wort, a herbal remedy (Hypericum perforatum)

-you have any kidney disease

-you have had convulsions (epileptic fits)

-you have had mania

-you have bipolar disorder

-you have eye problems, such as some types of glaucoma (increased eye pressure)

-you have a tendency to develop bleeding problems, especially if you are pregnant (see “Pregnancy, breastfeeding and fertility”).

-you have a risk of low sodium levels (for example, if you are taking diuretics, especially if you are an older person).

-you are being treated with other medicines that can damage the liver

-you are taking other medicines that contain duloxetine (see “Other medicines and Duloxetina Stada”)

Duloxetine may cause a feeling of restlessness or inability to sit or stay still. If this happens, tell your doctor.

You should also contact your doctor:

if you experience signs and symptoms of restlessness, hallucinations, loss of coordination, rapid heartbeats, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhea, coma, nausea, vomiting, as you may be suffering from a serotonin syndrome.

In its most severe form, serotonin syndrome can resemble neuroleptic malignant syndrome (NMS). The signs and symptoms of NMS can include a combination of fever, rapid heartbeats, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by a blood test).

Some medicines in the group to whichDuloxetina Stadabelongs (called SSRIs) may cause sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.

Thoughts of suicide and worsening of your depression or anxiety

If you are depressed and/or have anxiety disorders, you may occasionally have thoughts of self-harm or suicide. These thoughts may be increased at the beginning of treatment with antidepressants, as all these medicines take time to work, usually two weeks, but sometimes longer. You are more likely to have these thoughts if:

-you have had thoughts of self-harm or suicide before

-you are a young adult. There is information from clinical trials that has shown an increased risk of suicidal behaviour in adults under 25 years old who have a psychiatric disorder and are being treated with antidepressants.

Contact your doctor or go directly to the hospital immediately if you have any thoughts of self-harm or suicide.

It may be helpful to tell a close friend or family member that you are depressed or have an anxiety disorder, and ask them to read this leaflet. They may be able to tell you if your depression or anxiety is getting worse, or if they are concerned about changes in your behaviour.

Children and adolescents

Duloxetine should not normally be used in children and adolescents under 18 years old. You should also know that patients under 18 years old who take this type of medicine have an increased risk of side effects such as suicidal thoughts, suicidal attempts and hostility (mainly aggression, oppositional behaviour and irritability). Despite this, your doctor may prescribe duloxetine for patients under 18 years old because they decide it may be beneficial for the patient. If your doctor has prescribed duloxetine for a patient under 18 years old and you want to talk about it, please go back to your doctor. You should tell your doctor if any of the symptoms mentioned above appear or get worse in patients under 18 years old who are taking duloxetine. Additionally, in this age group, the long-term safety effects of duloxetine related to growth, maturation and development of cognitive and behavioural functions have not yet been demonstrated.

Other medicines and Duloxetina Stada

Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine.

The main component of Duloxetina Stada, duloxetine, is used in other medicines for other treatments:

•diabetic neuropathic pain, depression, anxiety and urinary incontinence

You should avoid using more than one of these medicines at the same time. Check with your doctor if you are already using other medicines that contain duloxetine.

Your doctor will decide if you can take Duloxetina Stada with other medicines.Do not start or stop using any medicine, including those bought without a prescription and herbal remedies, without first consulting your doctor.

You should also inform your doctor if you are taking any of the following medicines:

Monoamine oxidase inhibitors (MAOIs):You should not take duloxetine if you are taking, or have taken in the last 14 days, another antidepressant known as a monoamine oxidase inhibitor (MAOI). For example, moclobemide (an antidepressant) and linezolid (an antibiotic). Taking an MAOI with many prescription medicines, including duloxetine, can cause serious side effects, even life-threatening. You should wait at least 14 days after stopping treatment with an MAOI before taking duloxetine. Similarly, you should wait at least 5 days after stopping treatment with duloxetine before starting treatment with an MAOI.

Medicines that cause drowsiness:This includes prescription medicines prescribed by your doctor, such as benzodiazepines, powerful analgesics, antipsychotics, phenobarbital and antihistamines.

Medicines that increase serotonin levels:Triptans, tramadol, tryptophan, selective serotonin reuptake inhibitors (SSRIs, such as paroxetine and fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs, such as venlafaxine), tricyclic antidepressants (such as clomipramine, amitriptyline), pethidine, St. John's Wort and MAOIs (such as moclobemide and linezolid). These medicines increase the risk of side effects; if you observe any unusual symptoms when using any of these medicines with duloxetine, you should inform your doctor.

Oral anticoagulants or antiplatelet agents:Medicines that thin the blood or prevent the formation of blood clots. These medicines may increase the risk of bleeding.

Taking Duloxetina Stada with food, drinks and alcohol

Duloxetine Stada can be taken with or without food. You should be careful if you take alcohol while taking duloxetine.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medicine.

• Inform your doctor if you become pregnant or are trying to become pregnant while taking duloxetine. You should only use duloxetine after discussing the potential benefits and any potential risks for the foetus with your doctor.

• Make sure your midwife and/or doctor know that you are taking duloxetine. Other similar medicines (SSRIs), taken during pregnancy, may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe more rapidly and turn blue. These symptoms usually start within the first 24 hours after the baby's birth. If this happens to your baby, you should contact your midwife and/or doctor immediately.

• If you take duloxetine towards the end of your pregnancy, your baby may have some symptoms when it is born. These usually start at birth or within the first few days after the baby's birth. These symptoms may include weak muscles, trembling, nervousness, the baby not feeding properly, breathing problems and convulsions. If your baby has any of these symptoms when it is born or if you are concerned about your baby's health, contact your doctor or midwife, who can advise you.

• If you take duloxetine towards the end of your pregnancy, there is a higher risk of excessive vaginal bleeding shortly after birth, especially if you have had bleeding problems. Your doctor or midwife should know that you are taking duloxetine so that they can advise you.

• The available data on the use of duloxetine during the first three months of pregnancy do not show a general increase in the risk of birth defects in the baby. If you take duloxetine during the second half of pregnancy, there may be a higher risk of the baby being born prematurely (6 extra premature babies per 100 women taking duloxetine in the second half of pregnancy), especially between weeks 35 and 36 of pregnancy.

• Inform your doctor if you are breastfeeding. Duloxetine is not recommended during breastfeeding. Ask your doctor or pharmacist for advice.

Driving and operating machinery

During treatment with duloxetine, you may feel drowsy or dizzy. Do not drive or operate tools or machinery until you know how duloxetine affects you.

Duloxetina Stada contains saccharose

This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Dose

For depression and diabetic neuropathic pain:

The recommended dose of duloxetine is 60 mg once a day, but your doctor will prescribe the dose that is best for you.

For generalized anxiety disorder:

The initial normal dose of duloxetine is 30 mg once a day, after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is best for you. The dose can be adjusted to 120 mg per day depending on your response to duloxetine.

Administration form

Duloxetine should be taken orally. You should swallow the capsule whole with water.

To avoid forgetting to take duloxetine, it may be helpful to take it at the same time every day.

Duration of use

Discuss with your doctor for how long you should take duloxetine. Do not stop taking duloxetine, or change your dose without consulting your doctor. It is essential to treat your condition properly to help you improve. If you do not treat it, your condition may not disappear and may become more severe and more difficult to treat.

If you take moreDuloxetina Stadathan you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91.562.04.20 indicating the medication and the amount ingested.

Among the symptoms produced by an overdose are drowsiness, coma, serotonin syndrome (a rare reaction that can cause a feeling of intense happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle rigidity), seizures, vomiting, and high heart rate.

If you forgot to takeDuloxetina Stada

If you forget to take a dose, take it as soon as you remember. However, if it is time for the next dose, skip the missed dose and take a single dose as you normally do. Do not take a double dose to compensate for the missed doses. Do not take more duloxetine than prescribed for you in a day.

If you interrupt the treatment withDuloxetina Stada

DO NOT stop taking your capsules without your doctor's advice, even if you feel better. If your doctor thinks you no longer need to take duloxetine, they will instruct you to reduce your dose for at least 2 weeks before stopping treatment.

Some patients, who have stopped treatment with duloxetine abruptly, have presented symptoms such as:

•dizziness, feeling of pins and needles or electric shock sensation (especially in the head), sleep disturbances (intense dreams, nightmares, inability to sleep), fatigue, drowsiness, feeling of restlessness or agitation, feeling of anxiety, nausea or vomiting, tremors, headaches, muscle pain, feeling of irritability, diarrhea, and excessive sweating or vertigo.

These symptoms are usually not important and disappear in a few days, but if you have symptoms that are bothersome, ask your doctor for advice.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everyone will experience them. These side effects are usually mild to moderate and often disappear within a few weeks.

Very common side effects (may affect more than 1 in 10 people)

•headache, drowsiness

•unpleasantness (nausea), dry mouth

Common side effects (may affect up to 1 in 10 people)

•loss of appetite

•difficulty sleeping, feeling agitated, decreased sex drive, anxiety, difficulty or inability to have an orgasm, unusual dreams

•dizziness, feeling of slowness, tremor, numbness, including numbness, itching, or tingling in the skin

•blurred vision

•ringing in the ears (perception of sound in the ear when there is no sound outside)

•feeling palpitations in the chest

•increase in blood pressure, flushing

•increase in yawning

•constipation, diarrhea, stomach pain, vomiting, heartburn, or indigestion, gas

•increase in sweating, rash (itching)

•muscle pain, muscle spasms

•pain while urinating, urinating frequently

•difficulty achieving an erection, changes in ejaculation

•falls (mainly in older people), fatigue

•weight loss

The children and adolescents under 18 years of age with depression treated with this medicine experienced a decrease in weight when they started taking this medicine. After 6 months of treatment, the weight increased to similar levels of other children and adolescents of the same age and sex.

Uncommon side effects (may affect up to 1 in 100 people)

•inflammation of the throat that causes hoarseness

•suicidal thoughts, difficulty sleeping, grinding of teeth, feeling disoriented, lack of motivation

•muscle spasms and involuntary movements, feeling restless or inability to remain seated or still, nervousness, difficulty concentrating, changes in taste, difficulty controlling movements, e.g., lack of coordination or involuntary movements of the muscles, restless legs syndrome, poor quality sleep

•enlarged pupils (the black center of the eye), vision problems

•feeling dizzy or vertigo, ear pain

•rapid and/or irregular heartbeat

•loss of consciousness, dizziness, feeling dizzy or loss of consciousness when standing up, coldness in the fingers of the hands and/or feet

•throat spasms, nosebleed

•vomiting blood, or black stools, gastroenteritis, belching, difficulty swallowing

•inflammation of the liver that can cause abdominal pain and yellowing of the skin or the white part of the eyes

•night sweats, rashes, cold sweats, sensitivity to sunlight, increased tendency to bruise

•muscle stiffness, muscle spasms

•difficulty or inability to urinate, difficulty starting urination, need to urinate at night, need to urinate more than usual, decreased urine flow

•abnormal vaginal bleeding, abnormal menstrual periods, including heavy, painful, irregular, or prolonged periods, occasionally light or absent periods, testicular or scrotal pain

•chest pain, feeling cold, thirst, chills, feeling hot, alteration in gait

•weight gain

Duloxetine may cause effects that you may not be aware of, such as increased liver enzymes or blood levels of potassium, creatine phosphokinase, sugar, or cholesterol.

Rare side effects (may affect up to 1 in 1,000 people)

•severe allergic reactions, which cause difficulty breathing or dizziness with swelling of the tongue or lips, allergic reactions

•decreased activity of the thyroid gland, which can cause fatigue or weight gain

•dehydration, low sodium levels in the blood (mainly in older people; symptoms may include dizziness, weakness, confusion, sleepiness or excessive fatigue, nausea or vomiting, more serious symptoms are loss of consciousness, convulsions, or falls), syndrome of inadequate secretion of antidiuretic hormone (SIADH).

•suicidal behavior, mania (hyperactivity, accelerated thinking, and decreased need for sleep), hallucinations, aggression, and anger

•“Serotonin syndrome” (a rare reaction that can cause a feeling of intense happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle stiffness), convulsions

•increase in eye pressure (glaucoma)

•coughs, wheezing, and shortness of breath, which may be accompanied by high fever

•inflammation of the mouth, bright red blood in the stool, bad breath, inflammation of the large intestine (leading to diarrhea)

•liver failure, yellowing of the skin or the white part of the eyes (jaundice)

•Stevens-Johnson syndrome (a severe disease with blistering of the skin, mouth, eyes, and genitals), severe allergic reactions that cause swelling of the face or throat (angioedema)

•jaw muscle contractions

•unusual odor of urine

•menopausal symptoms, abnormal milk production in men or women

•excessive vaginal bleeding shortly after birth (postpartum hemorrhage)

Very rare side effects (may affect up to 1 in 10,000 people)

•inflammation of blood vessels in the skin (cutaneous vasculitis)

Unknown frequency (cannot be estimated from available data)

• signs and symptoms of a condition called “stress cardiomyopathy”, which may include chest pain, difficulty breathing, dizziness, loss of consciousness, and irregular heartbeat.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging, after CAD. The expiration date is the last day of the month indicated.

This medication does not require any special temperature for conservation.Store in the original packaging to protect it from moisture.

Medications should not be disposed of through drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE collection pointof the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. In this way, you will help protect the environment.

Composition ofDuloxetina Stada

- Theactive ingredientis duloxetina. Each gastro-resistant hard capsule contains 30 mg of duloxetina (as hydrochloride).

- Theothercomponents are:

Capule content:hypromellose, acetate succinate of hypromellose, sucrose, sugar spheres, talc, titanium dioxide (E171), hydroxypropyl cellulose.

Capsule coating:gelatin, titanium dioxide (E171), indigotin (E132).

Appearance of the product and contents of the package

Duloxetina Stada is a gastro-resistant hard capsule. Each capsule of Duloxetina Stada contains pellets of hydrochloride of duloxetina with a coating to protect them from stomach acid.

Duloxetina Stada is available in 2 doses: 30 and 60 mg.

The 30 mg capsules have a white body, dark blue cap, and are filled with gastro-resistant white pellets.

Duloxetina Stada 30 mg is presented in packages of 7, 10, 14, 28, 30, 50(blistered single-dose perforated), 56, 60, 84, 90, 98, 112 or 140 capsules.

Only some package sizes may be marketed.

Marketing authorization holder and responsible manufacturer

Marketing authorization holder

Laboratorio STADA, S.L.

Frederic Mompou 5

08960 Sant Just Desvern (Barcelona)

Spain

[email protected]

Responsible manufacturer

STADA Arzneimittel AG

Stadastrasse 2–18

61118 Bad Vilbel

Germany

or

STADA Arzneimittel GmbH

Muthgasse 36

1190 Wien

Austria

or

Centrafarm Services B.V.

Van de Reijtstraat 31-E

4814 NE Breda

Netherlands

or

Clonmel Healthcare Ltd.

Waterford Road

Clonmel, Co.Tipperary

Ireland

This medicinal product is authorized in the Member States of the European Economic Area with the following names:

ATDuloxetin STADA 30, 60 mg magensaftresistente Hartkapseln

BEDuloxetine Eurogenerics 30, 60 mg harde maagsapresistente capsules

DEDuloxetin STADA 30, 60 mg magensaftresistente Hartkapseln

DKDuloxetin STADA

ESDuloxetina Stada 30, 60 mg cápsulas duras gastrorresistentes EFG

FIDuloxetin STADA 30, 60 mg kova enterokapseli

FRDuloxetine EG 30, 60 mg, gélule gastro-résistante

LUDuloxetine Eurogenerics 30 mg gélules gastro-résistantes

HRDuloksetin Stada 30 mg/60 mg tvrde želucanootporne kapsule

HUDuloxetin STADA 30, 60 mg gyomornedv-ellenálló kemény kapszula

IEDuloxetine Clonmel 30, 60 mg hard gastro-resistant capsules

NLDuloxetine CF 30, 60 mg, maagsapresistente capsules, hard

PTDuloxetina Ciclum

RODuloxetina Stada 30, 60 mg capsule gastrorezistente

SEDuloxetin STADA 30, 60 mg enterokapslar, hårda

SKDuloxetin Stada 60mg tvrdé gastrorezistentné kapsuly

Last review date of this leaflet:October 2024.

The detailed information ofthis medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)